Guardian Life Insurance’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-2,074
Closed -$206K 537
2019
Q3
$206K Buy
2,074
+39
+2% +$3.71K 0.03% 99
2019
Q2
$188K Buy
2,035
+10
+0.5% +$950 0.03% 108
2019
Q1
$191K Buy
2,025
+33
+2% +$2.89K 0.02% 105
2018
Q4
$128K Buy
1,992
+8
+0.4% +$591 0.02% 128
2018
Q3
$178K Buy
1,984
+28
+1% +$2.47K 0.03% 106
2018
Q2
$155K Buy
1,956
+144
+8% +$12K 0.03% 111
2018
Q1
$162K Sell
1,812
-721
-28% -$69.2K 0.03% 92
2017
Q4
$264K Buy
2,533
+754
+42% +$85.1K 0.06% 85
2017
Q3
$259K Buy
1,779
+13
+0.7% +$1.77K 0.04% 61
2017
Q2
$229K Sell
1,766
-1,239
-41% -$152K 0.03% 57
2017
Q1
$374K Buy
3,005
+35
+1% +$4.19K 0.05% 63
2016
Q4
$344K Buy
2,970
+73
+3% +$8.13K 0.05% 75
2016
Q3
$303K Sell
2,897
-34
-1% -$3.68K 0.03% 110
2016
Q2
$289K Buy
2,931
+25
+0.9% +$2.59K 0.02% 133
2016
Q1
$291K Sell
2,906
-815
-22% -$83.9K 0.03% 129
2015
Q4
$446K Sell
3,721
-901
-19% -$104K 0.05% 115
2015
Q3
$500K Buy
4,622
+1,146
+33% +$142K 0.05% 118
2015
Q2
$402K Sell
3,476
-25
-0.7% -$2.86K 0.03% 119
2015
Q1
$404K Sell
3,501
-1,046
-23% -$125K 0.04% 129
2014
Q4
$509K Sell
4,547
-10
-0.2% -$1.05K 0.05% 122
2014
Q3
$432K Sell
4,557
-85
-2% -$7.67K 0.04% 124
2014
Q2
$399K Hold
4,642
0.04% 126
2014
Q1
$324K Hold
4,642
0.03% 153
2013
Q4
$392K Sell
4,642
-5,400
-54% -$427K 0.04% 137
2013
Q3
$773K Sell
10,042
-38
-0.4% -$2.66K 0.06% 137
2013
Q2
$589K Buy
+10,080
New +$607K 0.05% 153

Other funds holding CELG

Guardian Life Insurance's CELG Position: Q4 2019 in Review

Guardian Life Insurance sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 2,074 shares — an estimated $206K sold.

Guardian Life Insurance first reported a position in CELG in Q2 2013 and held it in 26 quarters. The position peaked at $773K in Q3 2013. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Guardian Life Insurance reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Guardian Life Insurance sold 2,074 Celgene Corp shares in Q4 2019, an estimated $206K.
  • Guardian Life Insurance first reported a position in Celgene Corp in Q2 2013 and held it in 26 quarters.
  • Guardian Life Insurance's Celgene Corp position peaked at $773K in Q3 2013.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Guardian Life Insurance's 13F filing for Q4 2019, filed 11 Feb 2020.